Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3240 |  ZNTL Zentalis Pharmaceuticals, Inc. - common stock | 4.81 USD | +0.63% | +11.09% | +34.36% | +278.74% | 342.41 M USD | ||
| 3250 |  OABI OmniAb, Inc. - Common Stock | 2.34 USD | +0.86% | -3.70% | +1.30% | +11.96% | 339.24 M USD | ||
| 3251 |  FATE Fate Therapeutics, Inc. - Common Stock | 2.91 USD | -3.64% | -2.02% | +50.78% | +162.16% | 339.19 M USD | ||
| 3262 |  IRD Opus Genetics, Inc. - Common Stock | 4.08 USD | +0.74% | -1.45% | +0.49% | +9.68% | 332.09 M USD | ||
| 3272 |  LCTX Lineage Cell Therapeutics, Inc. Common Stock | 1.32 USD | 0.00% | +0.76% | +9.09% | -23.26% | 329.07 M USD | ||
| 3305 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.35 USD | -0.42% | +13.53% | +48.73% | +422.22% | 316.22 M USD | ||
| 3329 |  ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.99 USD | +1.53% | +1.27% | +10.22% | +15.32% | 307.98 M USD | ||
| 3330 |  HELP Cybin Inc. - Common Stock | 5.96 USD | -1.16% | -7.31% | +47.16% | -33.56% | 307.73 M USD | ||
| 3343 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.65 USD | -4.62% | +2.48% | 0.00% | +83.33% | 305.72 M USD | ||
| 3351 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | -0.22% | +5.02% | +90.08% | +113.95% | 302.94 M USD | ||
| 3370 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.88 USD | -0.51% | +1.84% | +14.12% | +57.72% | 296.68 M USD | ||
| 3381 |  MGNX MacroGenics, Inc. - Common Stock | 4.63 USD | -2.53% | +1.31% | +18.11% | +210.74% | 294.30 M USD | ||
| 3387 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.96 USD | -0.90% | -1.87% | +42.08% | +8.73% | 292.64 M USD | ||
| 3388 |  FBRX Forte Biosciences, Inc. - Common Stock | 21.07 USD | -5.30% | -0.14% | +33.44% | -28.21% | 292.57 M USD | ||
| 3392 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 7.49 USD | +0.54% | +0.54% | +17.21% | +7.46% | 290.77 M USD | ||
| 3423 |  TTRX Turn Therapeutics Inc. - Common Stock | 9.30 USD | -4.22% | +33.05% | +82.35% | -7.00% | 277.03 M USD | ||
| 3432 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.42 USD | -9.36% | -17.97% | -9.02% | +27.37% | 274.05 M USD | ||
| 3438 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.41 USD | -1.16% | +2.71% | +1.19% | -31.53% | 271.59 M USD | ||
| 3442 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.02 USD | -1.46% | +2.02% | +22.42% | -0.98% | 266.71 M USD | ||
| 3443 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 18.16 USD | -2.21% | -21.42% | -18.53% | +79.98% | 266.56 M USD |
Haberler Biotechnology Stocks
TD Cowen, tahkim zaferi sonrası Prime Medicine hissesi için Al tavsiyesini korudu
BofA, tahkim kararı sonrası Beam hisse görüşünü korudu
Beam Therapeutics hisseleri neden düşüyor?
Prime Medicine hisseleri neden bugün yükseliyor?
Incyte hissesi 118,77 dolarda 52 haftalık zirve yaptı
Prime Medicine hisseleri Beam ile kazanılan tahkimden sonra yükseldi
Edgewise Therapeutics hissesi 43,96 dolarla rekor kırdı
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |